Phase 3 Study to Evaluate Efficacy and Safety of Oxcarbazepine Extended-Release in Subjects With Refractory Partial Seizures Due to Epilepsy When Used With up to 3 Other Antiepileptic Drugs.

This study has been completed.

Study NCT00772603 Information provided by Supernus Pharmaceuticals, Inc.

First Received: October 10, 2008 Last Updated: April 29, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	April 2010 (Final data collection date for primary outcome measure)